| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -53.70M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CGEM returned +164.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +109.5% |
| 1 year | +164.7% |
| 5 years | -23.2% |
| All-time high | $41.67 (Mar 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CGEM would be worth today ›No. Cullinan Therapeutics, Inc. has not paid a dividend in the past 12 months.
Cullinan Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol CGEM.
Cullinan Therapeutics, Inc. is part of the Healthcare sector.
Cullinan Therapeutics, Inc. has a market cap of 1.33B USD, based on the latest quote.
Cullinan Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
